drugset / Trial / NCT02468193
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The study aim was to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.
Timeline
- Start
- 2015-09-24
- Primary completion
- 2018-06-07
- Completion
- 2018-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | osilodrostat | Small molecule | 1 mg | Oral |
| Subject | osilodrostat | Small molecule | 5 mg | Oral |
| Subject | osilodrostat | Small molecule | 10 mg | Oral |